erlotinib hydrochloride has been researched along with mln 8237 in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (mln 8237) | Trials (mln 8237) | Recent Studies (post-2010) (mln 8237) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 246 | 43 | 236 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | mln 8237 (IC50) |
|---|---|---|---|
| Aurora kinase A | Homo sapiens (human) | 0.0088 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.32 | |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | 0.49 | |
| Ephrin type-A receptor 2 | Homo sapiens (human) | 0.048 | |
| Aurora kinase A | Mus musculus (house mouse) | 0.001 | |
| Aurora kinase B | Homo sapiens (human) | 0.5416 | |
| Inner centromere protein | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehra, R; Zibelman, M | 1 |
1 review(s) available for erlotinib hydrochloride and mln 8237
| Article | Year |
|---|---|
Overview of Current Treatment Options and Investigational Targeted Therapies for Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Topics: Afatinib; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azepines; Carcinoma, Squamous Cell; Cetuximab; Dasatinib; ErbB Receptors; Erlotinib Hydrochloride; Head and Neck Neoplasms; Humans; Lapatinib; Molecular Targeted Therapy; Panitumumab; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Quinazolinones; Signal Transduction; Sirolimus | 2016 |